Canopy Growth reported an 81% YoY increase in "rest-of-world" cannabis revenue for Q3 2024. The company attributed the growth to strong performance in Australia and a return to growth in Europe. Canopy also announced its plans for the US cannabis market through its non-controlling interest in Canopy USA. The company expects to file its definitive proxy statement with the SEC on or about 13 February, followed by a special meeting with shareholders on 12 April. During the meeting, shareholders will consider the creation of a new class of non-voting, non-participating exchangeable shares. Once exchangeable shares are created and Canopy USA acquires US THC businesses, investors are expected to have an opportunity to participate in the US cannabis market.